25 XP   0   0   10

Orexo AB
Buy, Hold or Sell?

Let's analyse Orexo together

PenkeI guess you are interested in Orexo AB. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Orexo AB. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Orexo AB

I send you an email if I find something interesting about Orexo AB.

Quick analysis of Orexo (30 sec.)










What can you expect buying and holding a share of Orexo? (30 sec.)

How much money do you get?

How much money do you get?
kr0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
kr1.71
Expected worth in 1 year
kr-2.21
How sure are you?
40.0%

+ What do you gain per year?

Total Gains per Share
kr-3.92
Return On Investment
-23.1%

For what price can you sell your share?

Current Price per Share
kr17.00
Expected price per share
kr13.70 - kr17.94
How sure are you?
50%

1. Valuation of Orexo (5 min.)




Live pricePrice per Share (EOD)

kr17.00

Intrinsic Value Per Share

kr8.79 - kr67.88

Total Value Per Share

kr10.50 - kr69.59

2. Growth of Orexo (5 min.)




Is Orexo growing?

Current yearPrevious yearGrowGrow %
How rich?$5.4m$25.9m-$16.7m-180.0%

How much money is Orexo making?

Current yearPrevious yearGrowGrow %
Making money-$2.9m-$4m$1.1m38.3%
Net Profit Margin-20.2%-28.6%--

How much money comes from the company's main activities?

3. Financial Health of Orexo (5 min.)




What can you expect buying and holding a share of Orexo? (5 min.)

Welcome investor! Orexo's management wants to use your money to grow the business. In return you get a share of Orexo.

What can you expect buying and holding a share of Orexo?

First you should know what it really means to hold a share of Orexo. And how you can make/lose money.

Speculation

The Price per Share of Orexo is kr17.00. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Orexo.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Orexo, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is kr1.71. Based on the TTM, the Book Value Change Per Share is kr-0.98 per quarter. Based on the YOY, the Book Value Change Per Share is kr-1.13 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is kr0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Orexo.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 kr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Share
Usd Eps-0.05-0.3%-0.09-0.5%-0.12-0.7%-0.05-0.3%-0.03-0.2%
Usd Book Value Change Per Share-0.09-0.5%-0.09-0.5%-0.10-0.6%-0.05-0.3%-0.010.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.09-0.5%-0.09-0.5%-0.10-0.6%-0.05-0.3%-0.010.0%
Usd Price Per Share1.42-1.32-1.78-3.63-4.91-
Price to Earnings Ratio-7.16--5.13--5.00--0.97-1.52-
Price-to-Total Gains Ratio-16.09--27.34--33.88--11.27--1.02-
Price to Book Ratio9.04-5.52-2.45-3.62-6.49-
Price-to-Total Gains Ratio-16.09--27.34--33.88--11.27--1.02-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.5623
Number of shares640
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.09-0.05
Usd Total Gains Per Share-0.09-0.05
Gains per Quarter (640 shares)-57.62-34.72
Gains per Year (640 shares)-230.49-138.89
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-230-2400-139-149
20-461-4700-278-288
30-691-7000-417-427
40-922-9300-556-566
50-1152-11600-694-705
60-1383-13900-833-844
70-1613-16200-972-983
80-1844-18500-1111-1122
90-2074-20800-1250-1261
100-2305-23100-1389-1400

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%5.015.00.025.0%15.025.00.037.5%21.043.014.026.9%
Book Value Change Per Share0.04.00.00.0%0.012.00.00.0%5.015.00.025.0%16.024.00.040.0%29.048.01.037.2%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.078.00.0%
Total Gains per Share0.04.00.00.0%0.012.00.00.0%5.015.00.025.0%16.024.00.040.0%29.048.01.037.2%

Fundamentals of Orexo

About Orexo AB

Orexo AB (publ), a specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, European Union, and internationally. Its products include Zubsolv tablets for the treatment of opioid use disorder; Abstral for the treatment of breakthrough pain in cancer patients; and Edluar for the treatment of insomnia. The company is developing OX124 for opioid overdose; OX125 for rescue medication and opioid overdose; OX640 for emergency treatment of allergic reactions; and OX-MPI for the treatment of endometriosis. In addition, its digital therapies include deprexis for the treatment of depression; vorvida for alcohol management; and modia for opioid use disorder. Orexo AB (publ) was founded in 1994 and is headquartered in Uppsala, Sweden.

Fundamental data was last updated by Penke on 2024-04-24 09:13:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Orexo AB.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Orexo earns for each kr1 of revenue.

  • Above 10% is considered healthy but always compare Orexo to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -11.2% means that kr-0.11 for each kr1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Orexo AB:

  • The MRQ is -11.2%. The company is making a huge loss. -2
  • The TTM is -20.2%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-11.2%TTM-20.2%+9.0%
TTM-20.2%YOY-28.6%+8.4%
TTM-20.2%5Y-15.5%-4.7%
5Y-15.5%10Y-10.8%-4.8%
1.1.2. Return on Assets

Shows how efficient Orexo is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Orexo to the Drug Manufacturers - Specialty & Generic industry mean.
  • -2.4% Return on Assets means that Orexo generated kr-0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Orexo AB:

  • The MRQ is -2.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -3.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-2.4%TTM-3.6%+1.2%
TTM-3.6%YOY-3.8%+0.2%
TTM-3.6%5Y-2.0%-1.6%
5Y-2.0%10Y-1.2%-0.8%
1.1.3. Return on Equity

Shows how efficient Orexo is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Orexo to the Drug Manufacturers - Specialty & Generic industry mean.
  • -31.6% Return on Equity means Orexo generated kr-0.32 for each kr1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Orexo AB:

  • The MRQ is -31.6%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -31.9%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-31.6%TTM-31.9%+0.3%
TTM-31.9%YOY-18.7%-13.1%
TTM-31.9%5Y-11.9%-20.0%
5Y-11.9%10Y-7.9%-3.9%

1.2. Operating Efficiency of Orexo AB.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Orexo is operating .

  • Measures how much profit Orexo makes for each kr1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Orexo to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of -0.6% means the company generated kr-0.01  for each kr1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Orexo AB:

  • The MRQ is -0.6%. The company is operating very inefficient. -2
  • The TTM is -16.1%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-0.6%TTM-16.1%+15.5%
TTM-16.1%YOY-34.5%+18.3%
TTM-16.1%5Y-12.3%-3.9%
5Y-12.3%10Y-7.6%-4.7%
1.2.2. Operating Ratio

Measures how efficient Orexo is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.01 means that the operating costs are kr1.01 for each kr1 in net sales.

Let's take a look of the Operating Ratio trends of Orexo AB:

  • The MRQ is 1.006. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.161. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.006TTM1.161-0.155
TTM1.161YOY1.345-0.184
TTM1.1615Y1.144+0.017
5Y1.14410Y1.089+0.055

1.3. Liquidity of Orexo AB.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Orexo is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.74 means the company has kr1.74 in assets for each kr1 in short-term debts.

Let's take a look of the Current Ratio trends of Orexo AB:

  • The MRQ is 1.744. The company is able to pay all its short-term debts. +1
  • The TTM is 1.804. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.744TTM1.804-0.060
TTM1.804YOY2.138-0.335
TTM1.8045Y2.216-0.413
5Y2.21610Y2.331-0.115
1.3.2. Quick Ratio

Measures if Orexo is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Orexo to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 1.46 means the company can pay off kr1.46 for each kr1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Orexo AB:

  • The MRQ is 1.458. The company is able to pay all its short-term debts with the most liquid assets. +1
  • The TTM is 1.684. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.458TTM1.684-0.226
TTM1.684YOY2.411-0.727
TTM1.6845Y2.073-0.389
5Y2.07310Y1.741+0.332

1.4. Solvency of Orexo AB.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Orexo assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Orexo to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.93 means that Orexo assets are financed with 92.5% credit (debt) and the remaining percentage (100% - 92.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Orexo AB:

  • The MRQ is 0.925. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.887. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ0.925TTM0.887+0.038
TTM0.887YOY0.765+0.122
TTM0.8875Y0.687+0.201
5Y0.68710Y0.700-0.013
1.4.2. Debt to Equity Ratio

Measures if Orexo is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Orexo to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 1,235.5% means that company has kr12.35 debt for each kr1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Orexo AB:

  • The MRQ is 12.355. The company is unable to pay all its debts with equity. -1
  • The TTM is 8.410. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ12.355TTM8.410+3.945
TTM8.410YOY3.382+5.029
TTM8.4105Y3.286+5.124
5Y3.28610Y3.042+0.245

2. Market Valuation of Orexo AB

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every kr1 in earnings Orexo generates.

  • Above 15 is considered overpriced but always compare Orexo to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -7.16 means the investor is paying kr-7.16 for every kr1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Orexo AB:

  • The EOD is -7.872. Based on the earnings, the company is expensive. -2
  • The MRQ is -7.158. Based on the earnings, the company is expensive. -2
  • The TTM is -5.129. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-7.872MRQ-7.158-0.713
MRQ-7.158TTM-5.129-2.029
TTM-5.129YOY-5.004-0.125
TTM-5.1295Y-0.970-4.159
5Y-0.97010Y1.522-2.493
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Orexo AB:

  • The EOD is -58.564. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -53.259. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -16.014. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-58.564MRQ-53.259-5.305
MRQ-53.259TTM-16.014-37.245
TTM-16.014YOY2.101-18.115
TTM-16.0145Y-2.325-13.689
5Y-2.32510Y5.977-8.302
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Orexo is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Orexo AB:

  • The EOD is 9.943. Based on the equity, the company is overpriced. -1
  • The MRQ is 9.042. Based on the equity, the company is overpriced. -1
  • The TTM is 5.520. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD9.943MRQ9.042+0.901
MRQ9.042TTM5.520+3.522
TTM5.520YOY2.453+3.067
TTM5.5205Y3.618+1.902
5Y3.61810Y6.494-2.876
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Orexo AB compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.961-0.980+2%-1.130+18%-0.590-39%-0.074-92%
Book Value Per Share--1.7102.930-42%8.205-79%12.053-86%10.541-84%
Current Ratio--1.7441.804-3%2.138-18%2.216-21%2.331-25%
Debt To Asset Ratio--0.9250.887+4%0.765+21%0.687+35%0.700+32%
Debt To Equity Ratio--12.3558.410+47%3.382+265%3.286+276%3.042+306%
Dividend Per Share----0%-0%-0%-0%
Eps---0.540-0.932+73%-1.290+139%-0.584+8%-0.332-39%
Free Cash Flow Per Share---0.073-0.849+1070%-1.310+1705%-0.729+905%-0.467+544%
Free Cash Flow To Equity Per Share---0.232-1.331+473%-1.465+531%-0.730+214%-0.086-63%
Gross Profit Margin--3.3013.045+8%2.453+35%1.886+75%0.926+257%
Intrinsic Value_10Y_max--67.875--------
Intrinsic Value_10Y_min--8.793--------
Intrinsic Value_1Y_max---0.616--------
Intrinsic Value_1Y_min---4.532--------
Intrinsic Value_3Y_max--3.803--------
Intrinsic Value_3Y_min---9.010--------
Intrinsic Value_5Y_max--15.037--------
Intrinsic Value_5Y_min---8.403--------
Market Cap585643200.000+9%532590816.000493835016.000+8%666599760.000-20%1379306094.340-61%1864352832.733-71%
Net Profit Margin---0.112-0.202+80%-0.286+155%-0.155+39%-0.108-4%
Operating Margin---0.006-0.161+2577%-0.345+5620%-0.123+1938%-0.076+1156%
Operating Ratio--1.0061.161-13%1.345-25%1.144-12%1.089-8%
Pb Ratio9.943+9%9.0425.520+64%2.453+269%3.618+150%6.494+39%
Pe Ratio-7.872-10%-7.158-5.129-28%-5.004-30%-0.970-86%1.522-570%
Price Per Share17.000+9%15.46014.335+8%19.350-20%39.502-61%53.477-71%
Price To Free Cash Flow Ratio-58.564-10%-53.259-16.014-70%2.101-2635%-2.325-96%5.977-991%
Price To Total Gains Ratio-17.693-10%-16.090-27.341+70%-33.876+111%-11.271-30%-1.025-94%
Quick Ratio--1.4581.684-13%2.411-40%2.073-30%1.741-16%
Return On Assets---0.024-0.036+51%-0.038+61%-0.020-17%-0.012-50%
Return On Equity---0.316-0.319+1%-0.187-41%-0.119-62%-0.079-75%
Total Gains Per Share---0.961-0.980+2%-1.130+18%-0.590-39%-0.074-92%
Usd Book Value--5412910.0009277305.000-42%25977832.500-79%38626948.500-86%33765856.645-84%
Usd Book Value Change Per Share---0.088-0.090+2%-0.104+18%-0.054-39%-0.007-92%
Usd Book Value Per Share--0.1570.269-42%0.754-79%1.108-86%0.969-84%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.050-0.086+73%-0.119+139%-0.054+8%-0.030-39%
Usd Free Cash Flow---229750.000-2688075.000+1070%-4146987.500+1705%-2275903.500+891%-1464054.305+537%
Usd Free Cash Flow Per Share---0.007-0.078+1070%-0.120+1705%-0.067+905%-0.043+544%
Usd Free Cash Flow To Equity Per Share---0.021-0.122+473%-0.135+531%-0.067+214%-0.008-63%
Usd Market Cap53820610.080+9%48945095.99045383437.970+8%61260517.944-20%126758230.070-61%171334025.328-71%
Usd Price Per Share1.562+9%1.4211.317+8%1.778-20%3.630-61%4.915-71%
Usd Profit---1709340.000-2949990.000+73%-4080360.000+139%-1811808.500+6%-1028553.990-40%
Usd Revenue--15255400.00014671835.000+4%14340995.000+6%15329839.0000%15352850.760-1%
Usd Total Gains Per Share---0.088-0.090+2%-0.104+18%-0.054-39%-0.007-92%
 EOD+5 -3MRQTTM+25 -9YOY+22 -125Y+15 -1910Y+9 -25

3.2. Fundamental Score

Let's check the fundamental score of Orexo AB based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-7.872
Price to Book Ratio (EOD)Between0-19.943
Net Profit Margin (MRQ)Greater than0-0.112
Operating Margin (MRQ)Greater than0-0.006
Quick Ratio (MRQ)Greater than11.458
Current Ratio (MRQ)Greater than11.744
Debt to Asset Ratio (MRQ)Less than10.925
Debt to Equity Ratio (MRQ)Less than112.355
Return on Equity (MRQ)Greater than0.15-0.316
Return on Assets (MRQ)Greater than0.05-0.024
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of Orexo AB based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5058.087
Ma 20Greater thanMa 5016.408
Ma 50Greater thanMa 10015.735
Ma 100Greater thanMa 20015.494
OpenGreater thanClose17.000
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in SEK. All numbers in thousands.

Summary
Total Assets786,600
Total Liabilities727,700
Total Stockholder Equity58,900
 As reported
Total Liabilities 727,700
Total Stockholder Equity+ 58,900
Total Assets = 786,600

Assets

Total Assets786,600
Total Current Assets458,900
Long-term Assets327,700
Total Current Assets
Cash And Cash Equivalents 171,000
Net Receivables 212,700
Inventory 42,400
Other Current Assets 32,800
Total Current Assets  (as reported)458,900
Total Current Assets  (calculated)458,900
+/-0
Long-term Assets
Property Plant Equipment 105,500
Intangible Assets 173,200
Long-term Assets  (as reported)327,700
Long-term Assets  (calculated)278,700
+/- 49,000

Liabilities & Shareholders' Equity

Total Current Liabilities263,200
Long-term Liabilities464,500
Total Stockholder Equity58,900
Total Current Liabilities
Short-term Debt 20,900
Accounts payable 36,500
Other Current Liabilities 205,800
Total Current Liabilities  (as reported)263,200
Total Current Liabilities  (calculated)263,200
+/-0
Long-term Liabilities
Long term Debt 448,400
Capital Lease Obligations 25,400
Long-term Liabilities Other 100
Long-term Liabilities  (as reported)464,500
Long-term Liabilities  (calculated)473,900
+/- 9,400
Total Stockholder Equity
Common Stock14,200
Retained Earnings -1,786,100
Accumulated Other Comprehensive Income 14,900
Other Stockholders Equity 1,815,900
Total Stockholder Equity (as reported)58,900
Total Stockholder Equity (calculated)58,900
+/-0
Other
Capital Stock14,200
Cash and Short Term Investments 171,000
Common Stock Shares Outstanding 34,450
Liabilities and Stockholders Equity 786,600
Net Debt 302,800
Net Invested Capital 507,300
Net Working Capital 195,700
Property Plant and Equipment Gross 185,300
Short Long Term Debt Total 473,800



Balance Sheet

Currency in SEK. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-03-312003-12-312002-12-31
> Total Assets 
33,248
45,152
0
106,017
79,082
71,846
97,601
371,310
391,012
370,570
366,285
379,932
332,499
295,016
257,214
801,873
703,499
760,026
707,681
702,025
768,813
696,735
683,153
649,334
597,864
765,505
708,246
712,691
664,145
870,095
813,360
546,101
488,400
688,300
564,500
481,755
502,800
591,700
643,200
772,330
744,100
915,100
1,171,600
1,225,886
1,240,400
1,182,700
1,110,000
1,016,304
1,023,200
1,085,500
1,072,600
1,018,800
936,100
976,200
1,033,300
1,003,900
1,035,400
1,173,500
1,208,300
1,286,700
1,367,400
1,440,100
1,545,300
1,501,100
1,550,400
1,463,000
1,328,200
1,232,900
1,433,500
1,344,900
1,312,100
1,273,700
1,205,700
1,271,000
1,203,500
1,109,000
949,300
926,900
869,000
786,600
786,600869,000926,900949,3001,109,0001,203,5001,271,0001,205,7001,273,7001,312,1001,344,9001,433,5001,232,9001,328,2001,463,0001,550,4001,501,1001,545,3001,440,1001,367,4001,286,7001,208,3001,173,5001,035,4001,003,9001,033,300976,200936,1001,018,8001,072,6001,085,5001,023,2001,016,3041,110,0001,182,7001,240,4001,225,8861,171,600915,100744,100772,330643,200591,700502,800481,755564,500688,300488,400546,101813,360870,095664,145712,691708,246765,505597,864649,334683,153696,735768,813702,025707,681760,026703,499801,873257,214295,016332,499379,932366,285370,570391,012371,31097,60171,84679,082106,017045,15233,248
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
259,737
0
0
193,951
156,521
108,247
273,157
224,092
263,608
216,908
321,169
388,956
355,993
298,700
501,500
368,800
293,039
289,600
447,700
464,900
544,296
478,300
625,800
885,800
936,421
952,600
924,400
855,800
830,434
844,700
913,700
907,100
833,700
759,600
805,000
850,800
827,400
860,800
997,800
994,400
1,059,500
1,065,900
1,138,700
1,236,400
1,221,200
1,243,000
1,057,000
927,200
831,600
1,024,500
943,900
892,900
865,500
813,400
882,000
827,700
735,500
589,300
568,700
518,100
458,900
458,900518,100568,700589,300735,500827,700882,000813,400865,500892,900943,9001,024,500831,600927,2001,057,0001,243,0001,221,2001,236,4001,138,7001,065,9001,059,500994,400997,800860,800827,400850,800805,000759,600833,700907,100913,700844,700830,434855,800924,400952,600936,421885,800625,800478,300544,296464,900447,700289,600293,039368,800501,500298,700355,993388,956321,169216,908263,608224,092273,157108,247156,521193,95100259,7370000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
188,220
0
0
107,061
87,414
50,432
190,853
165,645
135,798
0
242,497
294,340
246,859
212,400
426,100
306,200
228,067
218,900
300,700
91,900
105,643
30,700
110,600
299,200
284,480
289,300
282,100
201,200
198,124
233,000
252,900
276,900
282,400
250,600
294,300
370,700
327,900
437,500
494,800
516,600
589,800
647,400
697,000
812,900
816,800
861,400
677,200
593,300
505,300
725,500
679,700
588,100
504,100
437,800
244,200
122,400
132,200
142,400
251,100
184,200
171,000
171,000184,200251,100142,400132,200122,400244,200437,800504,100588,100679,700725,500505,300593,300677,200861,400816,800812,900697,000647,400589,800516,600494,800437,500327,900370,700294,300250,600282,400276,900252,900233,000198,124201,200282,100289,300284,480299,200110,60030,700105,64391,900300,700218,900228,067306,200426,100212,400246,859294,340242,4970135,798165,645190,85350,43287,414107,06100188,2200000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
223,500
321,500
219,600
136,500
0
0
0
000136,500219,600321,500223,5000000000000000000000000000000000000000000000000000000000000000000000000000
       Net Receivables 
2,337
3,415
0
6,473
7,087
7,153
58,412
9,616
16,239
16,676
33,571
20,470
24,800
31,559
28,394
39,516
37,902
51,180
54,463
51,727
110,355
52,621
77,718
55,832
49,034
74,777
48,870
114,923
204,499
66,807
76,297
77,151
56,100
49,700
35,700
36,656
29,100
30,900
144,000
49,637
54,400
80,100
113,100
169,678
183,200
194,500
224,600
229,290
229,200
281,300
269,400
203,000
192,200
217,800
208,000
245,200
217,200
308,800
297,300
292,000
252,200
291,100
286,400
272,500
241,600
253,600
213,200
217,800
190,200
168,500
211,500
214,000
298,000
330,000
295,000
309,000
245,700
250,500
269,300
212,700
212,700269,300250,500245,700309,000295,000330,000298,000214,000211,500168,500190,200217,800213,200253,600241,600272,500286,400291,100252,200292,000297,300308,800217,200245,200208,000217,800192,200203,000269,400281,300229,200229,290224,600194,500183,200169,678113,10080,10054,40049,637144,00030,90029,10036,65635,70049,70056,10077,15176,29766,807204,499114,92348,87074,77749,03455,83277,71852,621110,35551,72754,46351,18037,90239,51628,39431,55924,80020,47033,57116,67616,2399,61658,4127,1537,0876,47303,4152,337
       Other Current Assets 
1,101
751
0
4,674
0
0
0
543
0
0
0
340
0
0
0
6,310
0
0
0
57,535
0
0
77,718
60,667
49,034
74,777
48,870
119,845
204,499
66,807
76,297
82,445
56,100
49,700
35,700
-2
29,100
30,900
144,000
55,243
54,400
80,100
113,100
173,797
183,200
194,500
224,600
233,385
229,200
281,300
269,400
207,100
192,200
217,800
208,000
249,300
217,200
308,800
297,300
296,100
-100
291,100
100
100
-100
253,600
213,200
100
190,200
168,500
-100
-100
298,000
329,900
100
100
0
0
0
32,800
32,800000100100329,900298,000-100-100168,500190,200100213,200253,600-100100100291,100-100296,100297,300308,800217,200249,300208,000217,800192,200207,100269,400281,300229,200233,385224,600194,500183,200173,797113,10080,10054,40055,243144,00030,90029,100-235,70049,70056,10082,44576,29766,807204,499119,84548,87074,77749,03460,66777,7180057,5350006,3100003400005430004,67407511,101
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
442,288
0
0
489,202
492,813
489,617
492,348
484,154
449,083
447,237
548,926
424,404
190,108
189,700
186,800
195,700
188,716
213,100
144,000
178,300
228,034
265,800
289,300
285,800
289,465
287,800
258,300
254,200
185,870
178,500
171,900
165,500
185,100
176,500
171,200
182,500
176,500
174,600
175,700
213,900
227,200
301,500
301,400
309,000
279,900
307,300
406,000
401,000
401,300
409,000
401,000
419,200
408,200
392,200
389,000
375,800
373,500
360,000
358,200
350,900
327,700
327,700350,900358,200360,000373,500375,800389,000392,200408,200419,200401,000409,000401,300401,000406,000307,300279,900309,000301,400301,500227,200213,900175,700174,600176,500182,500171,200176,500185,100165,500171,900178,500185,870254,200258,300287,800289,465285,800289,300265,800228,034178,300144,000213,100188,716195,700186,800189,700190,108424,404548,926447,237449,083484,154492,348489,617492,813489,20200442,2880000000000000000000
       Property Plant Equipment 
816
1,984
0
2,277
2,736
2,687
2,843
3,160
3,471
5,080
6,086
6,392
11,969
23,696
45,386
57,790
56,527
54,466
52,435
50,317
48,824
47,988
46,219
45,814
45,345
44,296
42,602
41,666
41,750
41,661
40,592
39,241
39,000
37,700
36,200
35,123
33,500
33,300
32,800
33,255
32,300
31,300
30,200
29,080
28,200
26,600
25,600
24,685
23,700
22,900
23,100
22,100
21,500
20,800
20,000
20,100
19,400
20,300
19,500
20,200
87,700
84,900
84,000
79,000
101,000
93,600
106,200
115,100
119,200
124,300
123,600
125,200
123,200
121,600
116,900
122,100
112,200
115,400
114,500
105,500
105,500114,500115,400112,200122,100116,900121,600123,200125,200123,600124,300119,200115,100106,20093,600101,00079,00084,00084,90087,70020,20019,50020,30019,40020,10020,00020,80021,50022,10023,10022,90023,70024,68525,60026,60028,20029,08030,20031,30032,30033,25532,80033,30033,50035,12336,20037,70039,00039,24140,59241,66141,75041,66642,60244,29645,34545,81446,21947,98848,82450,31752,43554,46656,52757,79045,38623,69611,9696,3926,0865,0803,4713,1602,8432,6872,7362,27701,984816
       Goodwill 
0
13,238
0
0
0
0
0
0
0
8,988
8,988
8,988
8,988
8,988
16,013
16,030
16,030
16,030
16,032
16,030
16,030
16,030
16,030
17,987
17,987
17,682
17,800
17,679
17,681
17,681
33,806
33,448
33,300
26,100
25,500
25,827
25,300
26,100
25,900
26,403
26,400
26,700
26,800
27,412
27,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000000027,00027,41226,80026,70026,40026,40325,90026,10025,30025,82725,50026,10033,30033,44833,80617,68117,68117,67917,80017,68217,98717,98716,03016,03016,03016,03016,03216,03016,03016,03016,0138,9888,9888,9888,9888,988000000013,2380
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7,000
7,100
7,300
7,800
7,700
10,400
10,800
10,800
12,300
1,400
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000001,40012,30010,80010,80010,4007,7007,8007,3007,1007,000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
9,703
19,758
0
4,529
4,031
3,538
3,045
2,553
2,065
12,066
11,503
10,962
10,702
10,617
20,025
19,783
393,243
392,794
392,349
391,971
446,602
18,589
18,147
1,982
1,769
1,680
1,420
407,417
1,065
931
895
150,867
900
2,100
28,300
109,259
114,900
73,700
109,900
168,376
207,100
230,100
227,800
231,815
231,200
230,400
226,300
159,124
153,400
147,800
142,400
138,200
133,900
129,800
125,400
121,000
116,600
112,100
108,300
103,900
99,700
95,500
101,900
114,000
109,900
213,500
239,600
234,300
253,200
250,700
260,600
248,800
241,700
235,500
229,600
217,400
207,200
197,800
186,400
173,200
173,200186,400197,800207,200217,400229,600235,500241,700248,800260,600250,700253,200234,300239,600213,500109,900114,000101,90095,50099,700103,900108,300112,100116,600121,000125,400129,800133,900138,200142,400147,800153,400159,124226,300230,400231,200231,815227,800230,100207,100168,376109,90073,700114,900109,25928,3002,100900150,8678959311,065407,4171,4201,6801,7691,98218,14718,589446,602391,971392,349392,794393,24319,78320,02510,61710,70210,96211,50312,0662,0652,5533,0453,5384,0314,529019,7589,703
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
424,836
427,030
424,516
428,690
422,332
0
386,741
488,653
349,111
0
116,500
120,900
131,200
18,507
39,400
10,900
9,700
0
0
1,200
1,000
1,158
1,400
1,300
2,300
2,061
1,400
1,200
0
0
0
0
7,000
7,100
7,300
7,800
7,700
-100
10,800
10,800
12,300
1,400
1,500
800
800
18,500
-100
100
800
800
800
223,500
321,500
219,600
136,600
-100
800
173,300
173,300800-100136,600219,600321,500223,500800800800100-10018,5008008001,5001,40012,30010,80010,800-1007,7007,8007,3007,1007,00000001,2001,4002,0612,3001,3001,4001,1581,0001,200009,70010,90039,40018,507131,200120,900116,5000349,111488,653386,7410422,332428,690424,516427,030424,8360000000000000000000000
> Total Liabilities 
7,731
9,270
0
26,581
21,901
29,984
29,081
32,401
35,400
37,761
43,085
55,582
44,844
59,759
54,661
130,621
92,414
174,902
122,036
132,242
135,350
115,161
81,791
100,673
78,638
266,708
242,061
244,454
236,326
235,264
231,656
235,000
191,900
404,100
356,100
290,561
265,900
489,200
451,500
610,871
600,100
824,600
772,400
770,863
800,000
813,700
784,800
749,845
789,600
845,000
801,700
708,500
662,800
700,400
733,300
674,800
730,000
812,200
783,900
810,600
870,800
887,200
873,600
794,700
775,100
727,500
708,800
674,400
898,700
885,500
900,400
924,100
876,200
962,100
905,100
915,100
820,200
803,100
777,000
727,700
727,700777,000803,100820,200915,100905,100962,100876,200924,100900,400885,500898,700674,400708,800727,500775,100794,700873,600887,200870,800810,600783,900812,200730,000674,800733,300700,400662,800708,500801,700845,000789,600749,845784,800813,700800,000770,863772,400824,600600,100610,871451,500489,200265,900290,561356,100404,100191,900235,000231,656235,264236,326244,454242,061266,70878,638100,67381,791115,161135,350132,242122,036174,90292,414130,62154,66159,75944,84455,58243,08537,76135,40032,40129,08129,98421,90126,58109,2707,731
   > Total Current Liabilities 
7,731
9,270
0
26,581
21,901
29,984
29,081
18,618
28,541
30,995
34,278
50,407
39,757
54,216
51,761
119,987
82,099
164,081
111,879
121,827
114,967
93,676
45,200
66,968
57,117
156,106
130,717
140,010
135,627
132,143
117,366
118,115
81,800
291,000
235,900
168,921
144,700
371,000
433,500
497,145
489,200
321,100
270,300
268,065
297,400
313,700
287,200
251,597
292,100
347,200
303,200
309,500
322,700
699,800
730,000
349,900
404,800
488,500
457,100
483,400
496,900
516,000
537,900
461,000
461,600
444,500
407,000
601,300
344,600
340,300
356,600
380,200
339,500
431,100
375,300
385,900
305,700
304,000
309,700
263,200
263,200309,700304,000305,700385,900375,300431,100339,500380,200356,600340,300344,600601,300407,000444,500461,600461,000537,900516,000496,900483,400457,100488,500404,800349,900730,000699,800322,700309,500303,200347,200292,100251,597287,200313,700297,400268,065270,300321,100489,200497,145433,500371,000144,700168,921235,900291,00081,800118,115117,366132,143135,627140,010130,717156,10657,11766,96845,20093,676114,967121,827111,879164,08182,099119,98751,76154,21639,75750,40734,27830,99528,54118,61829,08129,98421,90126,58109,2707,731
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
45,200
66,968
57,117
156,106
130,717
0
135,627
132,143
117,366
0
81,800
291,000
235,900
0
133,600
359,800
52,300
0
202,700
2,400
2,400
0
2,400
0
0
0
0
0
0
0
339,400
340,000
340,600
319,100
143,200
319,800
0
0
19,900
20,800
21,600
21,400
20,600
19,800
19,200
243,600
18,700
19,800
19,800
20,200
20,200
20,600
21,200
20,600
22,200
21,800
21,300
20,900
20,90021,30021,80022,20020,60021,20020,60020,20020,20019,80019,80018,700243,60019,20019,80020,60021,40021,60020,80019,90000319,800143,200319,100340,600340,000339,40000000002,40002,4002,400202,700052,300359,800133,6000235,900291,00081,8000117,366132,143135,6270130,717156,10657,11766,96845,2000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
339,400
340,000
340,600
319,100
319,500
319,800
0
0
19,900
196,900
0
0
0
0
0
224,500
154,900
0
0
0
0
0
0
0
0
0
0
0
00000000000154,900224,50000000196,90019,90000319,800319,500319,100340,600340,000339,4000000000000000000000000000000000000000000000000000000
       Accounts payable 
1,551
1,993
0
10,067
0
0
0
3,951
0
0
0
19,175
0
0
0
51,785
0
0
0
17,840
0
0
0
18,064
0
0
0
25,478
0
0
0
118,115
0
0
0
19,790
0
0
0
138,009
0
0
0
28,850
0
0
0
34,893
0
0
0
36,000
0
0
0
45,500
0
0
0
47,700
0
0
0
49,400
0
0
0
47,000
0
0
0
49,200
0
249,300
193,000
86,600
156,100
138,000
157,000
36,500
36,500157,000138,000156,10086,600193,000249,300049,20000047,00000049,40000047,70000045,50000036,00000034,89300028,850000138,00900019,790000118,11500025,47800018,06400017,84000051,78500019,1750003,95100010,06701,9931,551
       Other Current Liabilities 
6,180
7,277
0
16,514
21,901
29,984
29,081
14,667
28,541
30,995
34,278
31,232
39,757
54,216
51,761
68,202
82,099
164,081
111,879
121,827
114,967
93,676
45,200
45,704
57,117
146,627
121,238
140,010
126,735
123,251
106,052
90,792
75,900
279,800
224,800
149,131
11,100
11,200
381,200
359,136
286,500
318,700
267,900
239,215
295,000
313,700
287,200
216,704
292,100
347,200
303,200
273,500
322,700
359,800
389,400
304,400
261,600
488,500
457,100
435,700
477,000
495,200
516,300
1,100
441,000
424,700
387,800
1,900
325,900
320,500
336,800
13,100
319,300
410,500
354,100
278,700
283,500
282,200
288,400
205,800
205,800288,400282,200283,500278,700354,100410,500319,30013,100336,800320,500325,9001,900387,800424,700441,0001,100516,300495,200477,000435,700457,100488,500261,600304,400389,400359,800322,700273,500303,200347,200292,100216,704287,200313,700295,000239,215267,900318,700286,500359,136381,20011,20011,100149,131224,800279,80075,90090,792106,052123,251126,735140,010121,238146,62757,11745,70445,20093,676114,967121,827111,879164,08182,09968,20251,76154,21639,75731,23234,27830,99528,54114,66729,08129,98421,90116,51407,2776,180
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10,415
0
0
36,591
33,705
21,521
110,602
111,344
104,444
100,699
103,121
114,290
116,885
110,100
113,100
120,200
121,640
121,200
118,200
18,000
113,726
110,900
503,500
502,100
502,798
502,600
500,000
497,600
498,248
497,500
497,800
498,500
399,000
340,100
600
3,300
324,900
325,200
323,700
326,800
327,200
373,900
371,200
335,700
333,700
313,500
283,000
301,800
73,100
554,100
545,200
543,800
543,900
536,700
531,000
529,800
529,200
514,500
499,100
467,300
464,500
464,500467,300499,100514,500529,200529,800531,000536,700543,900543,800545,200554,10073,100301,800283,000313,500333,700335,700371,200373,900327,200326,800323,700325,200324,9003,300600340,100399,000498,500497,800497,500498,248497,600500,000502,600502,798502,100503,500110,900113,72618,000118,200121,200121,640120,200113,100110,100116,885114,290103,121100,699104,444111,344110,60221,52133,70536,5910010,4150000000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
47,400
535,000
534,700
533,000
530,300
526,700
523,700
520,800
519,000
508,200
495,300
457,400
0
0457,400495,300508,200519,000520,800523,700526,700530,300533,000534,700535,00047,4000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
13,783
6,859
6,370
8,431
4,819
4,750
5,226
1,908
162
329
1,074
526
10,000
548
10,735
11,142
11,114
12,187
12,086
10,798
1,112
1,143
605
4,974
565
4,800
5,400
7,700
3,997
9,600
10,100
11,400
9,645
7,400
9,400
8,400
9,006
8,900
6,900
3,900
3,914
2,600
2,300
2,400
1,200
700
600
3,300
5,800
5,700
3,900
6,600
6,600
7,600
7,900
8,300
10,800
10,200
10,400
33,600
25,700
19,100
10,500
10,800
13,600
10,000
7,300
9,000
10,200
6,300
0
9,900
0
09,90006,30010,2009,0007,30010,00013,60010,80010,50019,10025,70033,60010,40010,20010,8008,3007,9007,6006,6006,6003,9005,7005,8003,3006007001,2002,4002,3002,6003,9143,9006,9008,9009,0068,4009,4007,4009,64511,40010,1009,6003,9977,7005,4004,8005654,9746051,1431,11210,79812,08612,18711,11411,14210,73554810,0005261,0743291621,9085,2264,7504,8198,4316,3706,85913,7830000000
> Total Stockholder Equity
25,517
35,882
35,882
79,436
57,181
41,862
68,520
338,909
355,612
332,809
323,200
324,350
287,655
235,257
202,553
671,252
611,085
585,124
585,645
569,783
633,463
581,574
601,362
548,661
519,226
498,797
466,185
468,237
427,819
634,831
581,704
311,101
296,500
284,200
208,400
191,194
236,900
102,500
191,700
161,459
144,000
90,500
399,200
455,023
440,400
369,000
325,200
266,459
233,600
240,500
270,900
310,300
273,300
275,800
300,000
329,100
305,400
361,300
424,400
476,100
496,600
552,900
671,700
706,400
775,300
735,500
619,400
558,500
534,800
459,400
411,700
349,600
329,500
308,900
298,400
193,900
129,100
123,800
92,000
58,900
58,90092,000123,800129,100193,900298,400308,900329,500349,600411,700459,400534,800558,500619,400735,500775,300706,400671,700552,900496,600476,100424,400361,300305,400329,100300,000275,800273,300310,300270,900240,500233,600266,459325,200369,000440,400455,023399,20090,500144,000161,459191,700102,500236,900191,194208,400284,200296,500311,101581,704634,831427,819468,237466,185498,797519,226548,661601,362581,574633,463569,783585,645585,124611,085671,252202,553235,257287,655324,350323,200332,809355,612338,90968,52041,86257,18179,43635,88235,88225,517
   Common Stock
2,504
3,428
0
3,695
3,695
3,695
3,829
5,317
5,317
5,317
5,321
5,554
5,555
5,584
5,584
8,647
8,647
8,647
8,647
8,647
8,987
8,987
9,360
9,360
9,360
9,360
9,361
9,361
9,362
11,940
11,940
11,946
296,500
284,200
208,400
11,983
236,900
102,500
191,700
13,166
144,000
90,500
399,200
13,738
440,400
369,000
325,200
13,834
233,600
240,500
270,900
13,900
273,300
275,800
300,000
14,100
305,400
361,300
424,400
14,200
496,600
552,900
671,700
14,200
775,300
735,500
619,400
14,200
534,800
459,400
411,700
14,200
329,500
308,900
298,400
14,200
129,100
123,800
92,000
14,200
14,20092,000123,800129,10014,200298,400308,900329,50014,200411,700459,400534,80014,200619,400735,500775,30014,200671,700552,900496,60014,200424,400361,300305,40014,100300,000275,800273,30013,900270,900240,500233,60013,834325,200369,000440,40013,738399,20090,500144,00013,166191,700102,500236,90011,983208,400284,200296,50011,94611,94011,9409,3629,3619,3619,3609,3609,3609,3608,9878,9878,6478,6478,6478,6478,6475,5845,5845,5555,5545,3215,3175,3175,3173,8293,6953,6953,69503,4282,504
   Retained Earnings Total Equity00000000000000000000000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
21,700
0
0
0
14,900
14,90000021,700000000000000000000000000000000000000000000000000000000000000000000000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,861,400
0
0
0
1,814,400
0
0
0
0
0
0
0
0
0
0
0
0
0000000000001,814,4000001,861,400000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,012,964
0
0
1,083,881
1,089,208
1,087,338
1,102,217
1,098,107
1,098,029
428,884
1,327,192
1,329,939
1,330,317
296,500
284,200
208,400
1,296,236
236,900
102,500
191,700
1,473,258
144,000
90,500
399,200
1,822,834
440,400
369,000
325,200
1,832,161
233,600
240,500
270,900
1,848,800
273,300
275,800
300,000
1,844,300
305,400
361,300
424,400
1,853,300
496,600
552,900
671,700
1,864,500
775,300
735,500
619,400
1,801,000
534,800
459,400
411,700
1,815,600
329,500
308,900
298,400
1,815,900
129,100
123,800
92,000
1,815,900
1,815,90092,000123,800129,1001,815,900298,400308,900329,5001,815,600411,700459,400534,8001,801,000619,400735,500775,3001,864,500671,700552,900496,6001,853,300424,400361,300305,4001,844,300300,000275,800273,3001,848,800270,900240,500233,6001,832,161325,200369,000440,4001,822,834399,20090,500144,0001,473,258191,700102,500236,9001,296,236208,400284,200296,5001,330,3171,329,9391,327,192428,8841,098,0291,098,1071,102,2171,087,3381,089,2081,083,881001,012,9640000000000000000000



Balance Sheet

Currency in SEK. All numbers in thousands.




Cash Flow

Currency in SEK. All numbers in thousands.




Income Statement

Currency in SEK. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue638,800
Cost of Revenue-166,000
Gross Profit472,800472,800
 
Operating Income (+$)
Gross Profit472,800
Operating Expense-595,500
Operating Income-122,700-122,700
 
Operating Expense (+$)
Research Development236,700
Selling General Administrative188,000
Selling And Marketing Expenses181,500
Operating Expense595,500606,200
 
Net Interest Income (+$)
Interest Income7,800
Interest Expense-41,200
Other Finance Cost-48,100
Net Interest Income-81,500
 
Pretax Income (+$)
Operating Income-122,700
Net Interest Income-81,500
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-140,300-105,100
EBIT - interestExpense = -163,900
-140,300
-87,100
Interest Expense41,200
Earnings Before Interest and Taxes (EBIT)-122,700-99,100
Earnings Before Interest and Taxes (EBITDA)-45,600
 
After tax Income (+$)
Income Before Tax-140,300
Tax Provision--14,800
Net Income From Continuing Ops-201,500-125,500
Net Income-128,300
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses761,500
Total Other Income/Expenses Net-17,60081,500
 

Technical Analysis of Orexo
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Orexo. The general trend of Orexo is BULLISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Orexo's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (71.4%) Bearish trend (-71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Orexo AB.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 17.60 < 17.80 < 17.94.

The bearish price targets are: 14.00 > 13.94 > 13.70.

Tweet this
Orexo AB Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Orexo AB. The current mas is .

The long score for the Moving Averages is 12/14.
The longshort score for the Moving Averages is 10/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Orexo AB Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Orexo AB. The current macd is 0.34118705.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Orexo price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Orexo. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Orexo price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Orexo AB Daily Moving Average Convergence/Divergence (MACD) ChartOrexo AB Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Orexo AB. The current adx is 29.80.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Orexo shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Orexo AB Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Orexo AB. The current sar is 17.54.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Orexo AB Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Orexo AB. The current rsi is 58.09. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 3/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
Orexo AB Daily Relative Strength Index (RSI) ChartOrexo AB Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Orexo AB. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Orexo price going up in the near term. +2
  • Trending down: The STOCH %K is trending down. -1
Orexo AB Daily Stochastic Oscillator ChartOrexo AB Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Orexo AB. The current cci is 114.98.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Orexo AB Daily Commodity Channel Index (CCI) ChartOrexo AB Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Orexo AB. The current cmo is 17.01.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Orexo AB Daily Chande Momentum Oscillator (CMO) ChartOrexo AB Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Orexo AB. The current willr is -28.57142857.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Orexo is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Orexo AB Daily Williams %R ChartOrexo AB Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Orexo AB.

Orexo AB Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Orexo AB. The current atr is 0.97225468.

Orexo AB Daily Average True Range (ATR) ChartOrexo AB Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Orexo AB. The current obv is -895,728.

Orexo AB Daily On-Balance Volume (OBV) ChartOrexo AB Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Orexo AB. The current mfi is 42.34.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Orexo AB Daily Money Flow Index (MFI) ChartOrexo AB Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Orexo AB.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-06STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-07STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-11RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-29WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-08MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-10DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-19MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-24MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-31CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-13CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-14CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-29WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-07RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-20WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-25CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-26MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-04-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-12STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-16CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-23STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-04-25CCI LONG ENTRY SHORT CLOSE100 crossover to upside

6.3. Candlestick Patterns

Orexo AB Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Orexo AB based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5058.087
Ma 20Greater thanMa 5016.408
Ma 50Greater thanMa 10015.735
Ma 100Greater thanMa 20015.494
OpenGreater thanClose17.000
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Orexo with someone you think should read this too:
  • Are you bullish or bearish on Orexo? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Orexo? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Orexo AB

I send you an email if I find something interesting about Orexo AB.


Comments

How you think about this?

Leave a comment

Stay informed about Orexo AB.

Receive notifications about Orexo AB in your mailbox!